Barbara Trautner, MD:
“If you ask me if there is increasing evidence of antibiotic resistance in complicated UTIs, the answer is yes, and this creates challenges for us in management.”
The second episode in our series looks to address clinical management in a time when antimicrobial resistance appears to be growing.
We want to welcome you to the second episode from our complicated UTI roundtable series, which is a collaborative effort that includes Contemporary Pediatrics, Contagion, and Contemporary OB/GYN. This series looks to discuss several topics around these infections including diagnosis, treatment, challenges in managing UTIs in patients with dementia and neurogenic bladders, antibiotic resistance, and considerations for patients and caregiver engagement.
“If you ask me if there is increasing evidence of antibiotic resistance in complicated UTIs, the answer is yes, and this creates challenges for us in management.”
Our panel of clinicians includes:
· Barbara Trautner, MD, PhD, professor, Infectious Diseases, Section of Health Services Research, Baylor College of Medicine
· Kimberly Claeys, PharmD, associate professor of Practice, Sciences, and Health Outcomes Research, University of Maryland Baltimore
· Laila Woc-Colburn, MD, associate professor, Division of Infectious Diseases, Emory University School of Medicine
This is a 3-part series, and in today’s episode, the clinicians discuss diagnosing and managing UTIs in patients with dementia and neurogenic bladders, if these infections are becoming more antibiotic resistant, and how resistance affects how they prescribe treatments.
This roundtable is part of ongoing educational and informational multimedia series we are producing and for any feedback or suggestions, please feel free to email John Parkinson at jparkinson@mjhlifesciences.com.